andrographolide

signal transducer and activator of transcription 3 ; Homo sapiens







8 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35599281 Synergistic antitumor effect of Andrographolide and cisplatin through ROS-mediated ER stress and STAT3 inhibition in colon cancer. 2022 May 23 1
2 29511440 Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23/IL-17 axis. 2018 2
3 27993634 An ex vivo evaluation of the efficacy of andrographolide in modulating differential expression of transcription factors and target genes in periodontal cells and its potential role in treating periodontal diseases. 2017 Jan 20 1
4 25613753 SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line. 2015 1
5 24803294 Andrographolide suppresses IL-6/Stat3 signaling in peripheral blood mononuclear cells from patients with chronic rhinosinusitis with nasal polyps. 2014 Oct 2
6 23845849 Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer. 2013 Sep 12 1
7 20026083 Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin. 2010 May 1 2
8 21442031 Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. 2010 Aug 1